Cevenfacta Evrópusambandið - íslenska - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Ferinject Stungulyf/innrennslislyf, ördreifa 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ferinject stungulyf/innrennslislyf, ördreifa 50 mg/ml

vifor france - ferricum carboxymaltosum inn - stungulyf/innrennslislyf, ördreifa - 50 mg/ml